The success of Sildenafil initially fueled a period of growth for the drug industry, but recent developments present a murky outlook for shareholders. Off-patent alternatives are eroding earnings, and ongoing https://imogenlfol863306.fare-blog.com/41584874/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet